Structure Therapeutics is trading 7.92% down in after-hours trading at $48.00, with no reliable company-specific announcement or late-breaking event identified to explain the decline.
- It closed at $52.13 on August 11, 2026.
- Its August 6 earnings update reported $1.3 billion in cash, a runway through 2028, and Phase 3 ACCOMPLISH dosing.
- The update did not attribute any subsequent price movement to those developments.